Ablynx NV
Alligator Bioscience AB
Apogenix AG
Avacta Life Sciences Ltd
Bristol-Myers Squibb Co
Checkpoint Therapeutics Inc
GigaGen Inc
Incyte Corp
Leap Therapeutics Inc
Merck & Co Inc
Novartis AG
Regeneron Pharmaceuticals Inc
Published | Pages | Publisher | Report code |
---|---|---|---|
Mar 2019 | 62 | Global Markets Direct | ASDR-483923 |
Ablynx NV
Alligator Bioscience AB
Apogenix AG
Avacta Life Sciences Ltd
Bristol-Myers Squibb Co
Checkpoint Therapeutics Inc
GigaGen Inc
Incyte Corp
Leap Therapeutics Inc
Merck & Co Inc
Novartis AG
Regeneron Pharmaceuticals Inc